Loading issues…
- Getting our AKTA-gether: Using the AKTA Flux to purify phages for patientsThis week I’m excited to share how I’ve been using the AKTA Flux system to purify phages for patients. What used to be overwhelming now feels pretty dreamy. Worth considering for any phage lab making patient-ready preps!

- Evergreen turns 50: celebrating Dr. Betty Kutter’s legacyThis week, we’re proud to open up registration for the Evergreen Phage Meeting. This year’s Evergreen phage meeting will be in-person (!), absolutely packed with science and activities (!!), and will be a celebration of both Betty’s…

- Discovering coding (& building an AI tool) as a biologist, thanks to ChatGPTThis week, Jessica Sacher shows you how, as a non-coder, she got ChatGPT to help her make a chatbot that knows everything we've published across 220 Capsid & Tail blog posts (almost every week for the last 4.5 years!), how you can play with…

- qPCR for phage therapy, part IIThis week Jessica Sacher continues her 'qPCR for phage therapy' series. She takes us through how we know if our qPCR worked, what to look for, and how to interpret how much phage/bacteria were in our samples based on the results.

- qPCR as a window into phage therapyThis week Jessica Sacher talks about how to use qPCR to count phage and bacteria in patients during phage therapy. This is part I of a multipart series.

- Lessons in scaling bio, team science & prioritiesThis week, Jessica Sacher shares learnings from setting up a pipeline for phage production/purification/QC at Phage Australia, and using it to provide phage therapy for our first 3 patients in 2022! Biggest learning: the hardest part about…

- Investing in the future of phage therapyThis week, we're republishing an article Dr. Jon Iredell and Jessica Sacher wrote for GARDP Revive, the Global Antibiotic Research & Development Partnership.

- 2023: A look aheadWell hello there, 2023! We’ve made great strides in the past year, gotten our hands wet in the lab (Jessica at least 😉), built data systems, and even delivered phages for patients. This year we aim to do a whole lot more of that! This…

- Reflecting back on 2022We’re at the end of the year again, and what a whirlwind of a 2022 it’s been! Here's our annual end-of-year reflection on what we're most proud of, what we've accomplished, & those who've helped us along the way!

- C&T Round Up for September 2022!This week, we highlight the feature articles we published in September! Learn about main themes from Phage Futures Europe 2022, MetaPhage: a new pipeline for turning raw reads into phage insights, and how to set up a basic phage QC system…

- How do we prove our phages are safe?Patients need safe phages, but most regulators don't yet have official positions on what makes a phage batch safe. This week, Jessica Sacher (Iredell lab, Phage Australia) shares her recent foray into learning about phage quality control…

- C&T Round Up for August 2022!This week, we highlight the feature articles we published in August! Learn about phage+AI and how you can get involved, what happened at Phage Futures this year, how phage-making is going at Phage Australia, and meet Phage Directory's…

- Therapeutic phage-making: how my first batch measured upThis week Jessica Sacher shares an update on her work toward setting up a new phage-making system in the Iredell lab (part of Phage Australia).

- We have the best volunteers!Our lovely phage community would not exist without the hard work of some incredible phage enthusiasts! This week, we're recognizing a few of our Phage Directory volunteers for some great stuff they've done lately.

- C&T Round Up for July 2022!This week, we highlight the feature articles we published in July! Learn about Intralytix's past and present, navigating complexity when you start making phages for therapy, and the new phage-bacteria interaction atlas the Gates Foundation…

- How to start making phages for therapyThis week Jessica Sacher takes us through her process for setting up a new phage-making system in the lab, including making sense of a dizzying array of options, managing overwhelm, and resisting 'optimization creep'.

- C&T Round Up for June 2022!This week, we highlight the feature articles we published in June! Learn about what happened when the Phage Australia team shipped a phage around the country, Jean-Paul Pirnay's views on phage therapy, and how producing phages has changed…

- C&T Round Up for May 2022!This week, we highlight the feature articles we published in May! Learn about the latest Mycobacterium phage treatment, how we might make our spot tests less subjective, how to get involved in DeSci, and what a phage biologist thought of…

- Diving into a DAO as a scientist: what does help look like?You may have heard people (especially on Twitter) talking about DeSci, or decentralized science. Today Jessica Sacher shares her experience diving into LabDAO, a new DeSci initiative enabling science through a lab space/experiment sharing…

- 500 days of phage beats M. abscessus in the CF lungThis week, we highlight a new case report published last week in Cell. It documents the successful phage therapy of a Mycobacterium abscessus infection, which led a 26-year old in Colorado with cystic fibrosis to receive a lung transplant…

